Metacrine Current Assets

Metacrine (MTCR) currently reports a current assets of $55M as of September 2022. That compares with $66M in the prior-year period — down 16.1% year over year. Use the charts on this page to explore Metacrine's current assets history and peer comparisons.

Metacrine's current assets decreased from $66M to $55M — a 16.1% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Metacrine reported $55M in current assets as of September 2022. That compares with $66M in the prior-year period — down 16.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $55M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Metacrine, and consider following MTCR for alerts when major investors trade the stock.

Metacrine is classified in the Healthcare sector. On current assets, it currently shows $55M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MTCR with unrelated industries.